Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Dietary Supplements

Chiavna Saffron LLC: Super Panther 7K Capsules Recalled for Undeclared Drug Ingredients

Agency Publication Date: September 12, 2017
Share:
Sign in to monitor this recall

Summary

Chiavna Saffron LLC is recalling approximately 211 bottles and 339 boxes of Super Panther 7K Capsules (1250 mg blend) because FDA analysis found the product contains sildenafil and tadalafil. These are active drug ingredients found in prescription medications like Viagra and Cialis that are not listed on the packaging. The recall includes 6-count bottles and individual blister cards shipped in boxes of 30, all marked with expiration dates of August 28, 2020. Consumers should stop using the product immediately and contact a healthcare professional.

Risk

The undeclared ingredients sildenafil and tadalafil can interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels. This poses a severe risk to consumers with heart disease, high blood pressure, diabetes, or high cholesterol, who often take prescription nitrates.

What You Should Do

  1. Identify if you have Super Panther 7K Capsules 1250 mg blend in either 1-count blister cards (UPC 6015577513247) or 6-count bottles (UPC 601577513209).
  2. Check the packaging for lot number RO846356 with expiration date 8/28/2020 (blister cards) or lot number RO246852 with expiration date 8/28/2020 (bottles).
  3. Stop using these capsules immediately as they contain unapproved drug ingredients that can cause serious health complications.
  4. Contact your healthcare provider or pharmacist for guidance regarding any potential side effects or health concerns you may have.
  5. Return any unused product to the place of purchase for a refund and contact Chiavna Saffron LLC at 14235 Boren St, Apt 201, Huntersville, North Carolina for further instructions.
  6. For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

๐Ÿ’ฐFull Refund

Full refund upon return of unused product.

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the place of purchase for a refund and contact the manufacturer for further instructions.

Affected Products

Product: Super Panther 7K Capsules 1250 mg blend (1 count blister cards)
Model:
D-1145-2017
UPC Codes:
6015577513247
Lot Numbers:
RO846356 (Exp. 8/28/2020)
Date Ranges: Exp. 8/28/2020
Product: Super Panther 7K Capsules 1250 mg blend (6 count bottles)
Model:
D-1145-2017
UPC Codes:
601577513209
Lot Numbers:
RO246852 (Exp. 8/28/2020)
Date Ranges: Exp. 8/28/2020

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 77812
Status: Resolved
Manufacturer: Chiavna Saffron LLC
Sold By: SX Power CO.
Manufactured In: United States
Units Affected: 211 bottles; 339 boxes
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.